13F Notebook
← Dashboard
Fund detail

Viking Global Investors (Halvorsen)

hedge-fund, active

Quarters 52
2024-06-30 $26.02B
Positions 82
Showing 12 of 12 rows (filtered from 108)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 BRIDGEBIO PHARMA INC BBIO $636.3M 2.45% 25,120,991 +0 +0.00% 2.89% 2019-06-30 $25 ~$27 -6.08%
2 NEWAMSTERDAM PHARMA COMPANY $154.2M 0.59% 8,024,565 +0 +0.00% 0.71% 2022-12-31 $19 ~$11 +70.66%
3 ADAPTIVE BIOTECHNOLOGIES COR ADPT $108.6M 0.42% 29,993,708 +0 +0.00% 0.36% 2019-06-30 $4 ~$48 -92.51%
4 STANDARD BIOTOOLS INC LAB $103.8M 0.40% 58,651,170 +0 +0.00% 0.59% 2024-03-31 $2 ~$3 -34.69%
5 PHARVARIS N V $68.7M 0.26% 3,653,310 +0 +0.00% 0.31% 2021-03-31 $19 ~$24 -20.41%
6 4D MOLECULAR THERAPEUTICS IN FDMT $61.6M 0.24% 2,934,914 +0 +0.00% 0.35% 2020-12-31 $21 ~$37 -43.61%
7 GINKGO BIOWORKS HOLDINGS INC DNA4EUR $47.8M 0.18% 143,085,126 +0 +0.00% 0.62% 2021-09-30 $0 ~$3 -89.19%
8 DAY ONE BIOPHARMACEUTICALS I DAWNGBX $35.3M 0.14% 2,558,563 +0 +0.00% 0.16% 2021-06-30 $14 ~$17 -17.89%
9 ORIC PHARMACEUTICALS INC ORIC $28.3M 0.11% 4,000,000 +0 +0.00% 0.20% 2024-03-31 $7 ~$14 -48.58%
10 PEPGEN INC PEPG $23.7M 0.09% 1,482,434 +0 +0.00% 0.08% 2022-06-30 $16 ~$10 +60.72%
11 TREVI THERAPEUTICS INC TRVI $13.1M 0.05% 4,400,000 +0 +0.00% 0.06% 2022-09-30 $3 ~$2 +93.51%
12 RALLYBIO CORP $5.6M 0.02% 4,194,777 +0 +0.00% 0.03% 2021-09-30 $1 ~$18 -92.38%